Prevalence of chronic kidney disease and associated factors among the Chinese population in Taian, China Epidemiology and Health Outcomes

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Xue, Lingyu ^a   Lou, Yanxia ^b   Feng, Xiaoqing ^a   Wang, Chuaihai ^a   Ran, Zhangshen ^a   Zhang, Xuebin ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b Departments of Ophthalmology   (China)

Author keywords

Awareness; Chronic kidney disease; Epidemiology; Prevalence; Risk factors

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATURIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREVALENCE; PRIMARY MEDICAL CARE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ADOLESCENT; AGE DISTRIBUTION; CHINA; COMORBIDITY; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SOCIOECONOMICS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALBUMINURIA; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84926312155     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-205     Document Type: Article

References (37)

1. Trautmann A, Schmid-Grendelmeier P, Krüger K, Crameri R, Akdis M, Akkaya A, Bröcker E-B, Blaser K, Akdis CA: T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol 2002,109(2):329-337. 10.1067/mai.2002.121460
2. Hakemi MS: Chronic kidney disease epidemiology. Iran J Kidney Dis 2014,8(4):261-262.
3. Zhang QL, Koenig W, Raum E, Stegmaier C, Brenner H, Rothenbacher D: Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009,48(2):122-127. 10.1016/j.ypmed.2008.10.026
4. Stauffer ME, Fan T: Prevalence of anemia in chronic kidney disease in the United States. PLoS One 2014,9(1):e84943. 10.1371/journal.pone.0084943
5. Mallett A, Patel C, Salisbury A, Wang Z, Healy H, Hoy W: The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia. Orphanet J Rare Dis 2014, 9:98. 10.1186/1750-1172-9-98
6. Nugent RA, Fathima SF, Feigl AB, Chyung D: The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011,118(3):c269-277. 10.1159/000321382
7. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang J, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H: Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012,379(9818):815-822. 10.1016/S0140-6736(12)60033-6
8. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003,41(1):1-12. 10.1053/ajkd.2003.50007
9. Carney EF: Chronic kidney disease: Paradoxical association between serum IL-10 levels and risk of cardiovascular events. Nat Rev Nephrol 2014,10(7):362.
10. Kong X, Ma X, Cui M, Xu D: Association of clustering of major cardiovascular risk factors with chronic kidney disease in the adult population. Clin Nephrol 2014,82(2):92-97.
11. Gomez-Huelgas R, Martinez-Castelao A, Artola S, Gorriz JL, Menendez E: Treatment of type 2 diabetes mellitus in patients with chronic kidney disease]. Med Clin (Barc) 2014,142(2):85 e81-10.
12. Bingham CO 3rd, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM: Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford) 2007,46(3):496-507. 10.1093/rheumatology/kel296
13. Allison SJ: Chronic kidney disease: ESRD risk in CKD patients with incident atrial fibrillation. Nat Rev Nephrol 2013,9(3):125.
14. Bello AK, Nwankwo E, El Nahas AM: Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl 2005, 98:S11-17.
15. Yang SH, Dou KF, Song WJ: Prevalence of diabetes among men and women in China. N Engl J Med 2010,362(25):2425-2426. author reply 2426
16. Zhang L, Yuan Z, Maddock JE, Zou J, Zheng Z, Zhou W, Zheng H: Chronic disease prevalence and influencing factors among rural residents in Jiangxi. China Int Health 2014,6(2):106-111. 10.1093/inthealth/ihu022
17. Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, Ongaiyooth L, Vanavanan S, Sirivongs D, Thirakhupt P, Mittal B, Singh A, and the Thai-SEEK Group: Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2010,25(5):1567-1575. 10.1093/ndt/gfp669
18. Chen W, Wang H, Dong X, He H, Liu Q, Luo N, Tan J, Lin J, Nie J, Mao H, Chen W, Yu X: Epidemiologic study of chronic kidney disease in Guangzhou urban area (in Chinese). Chin J Nephrol 2007, 23:147-151.
19. Guo L, Zhang L, Wang X, Zhang P, Zhao Q, Wang F, Wang H: Screening for chronic kidney disease in a village of Zhejiang province (in Chinese). Chin J Nephrol 2007, 23:152-156.
20. Zhang L, Zuo L, Xu G, Wang F, Wang M, Wang S, Lv J, Liu L, Wang H: Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant 2007,22(4):1093-1099. 10.1093/ndt/gfl763
21. Chen W, Wang H, Dong X, Liu Q, Mao H, Tan J, Lin J, Zhou F, Luo N, He H, Johnson R, Zhou S, Yu X: Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 2009,24(4):1205-1212.
22. Chen W, Liu Q, Wang H, Johnson RJ, Dong X, Li H, Ba S, Tan J, Luo N, Liu T, He H, Yu X: Prevalence and risk factors of chronic kidney disease: a population study in the Tibetan population. Nephrol Dial Transplant 2011,26(5):1592-1599. 10.1093/ndt/gfq608
23. Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, Li G, Jiao S, Liu Z, Liang W: Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008,51(3):373-384. 10.1053/j.ajkd.2007.11.009
24. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY, and on behalf of the Chinese eGFR Investigation Collaboration: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006,17(10):2937-2944. 10.1681/ASN.2006040368
25. Bailey RA, Wang Y, Zhu V, Rupnow MF: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes 2014,7(1):415. 10.1186/1756-0500-7-415
26. Jin S: The Tenth Report of the Chinese National Health and Nutrition Examination Survey - Nutrition and Health Status, 1st ed In. Beijing: People's Medical Publishing House; 2008.
27. Liu LS: Epidemiology of hypertension and cardiovascular disease-China experience. Clin Exp Hypertens A 1990,12(5):831-844.
28. Chidambaram N, Sethupathy S, Saravanan N, Mori M, Yamori Y, Garg AK, Chockalingam A: Relationship of Sodium and Magnesium Intakes to Hypertension Proven by 24-Hour Urianalysis in a South Indian Population. J Clin Hypertens (Greenwich) 2014,16(8):581-586. 10.1111/jch.12361
29. Xie Y, Chen X: Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am J Nephrol 2008,28(1):1-7. 10.1159/000108755
30. Mazzali M, Jefferson JA, Ni Z, Vaziri ND, Johnson RJ: Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 2003,63(6):2088-2093. 10.1046/j.1523-1755.2003.00011.x
31. Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A, Ballal HS, P G, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rana DS, Sreedhara R, Sinha DK, V SB, Sunder S, Sharma RK, Seetharam S, Raju TR, Rajapurkar MM: Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol 2013, 14:114. 10.1186/1471-2369-14-114
32. Alsuwaida AO, Farag YM, Al Sayyari AA, Mousa D, Alhejaili F, Al-Harbi A, Housawi A, Mittal BV, Singh AK: Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl 2010,21(6):1066-1072.
33. Lu C, Schneider MT, Gubbins P, Leach-Kemon K, Jamison D, Murray CJ: Public financing of health in developing countries: a cross-national systematic analysis. Lancet 2010,375(9723):1375-1387. 10.1016/S0140-6736(10)60233-4
34. Wang F, Zhang L, Wang H: Awareness of CKD in China: a national cross-sectional survey. Am J Kidney Dis 2014,63(6):1068-1070.
35. Hallan SI, Stevens P: Screening for chronic kidney disease: which strategy? J Nephrol 2010,23(2):147-155.
36. Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C: Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess 2010,14(21):1-184.
37. The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2369/15/205/prepub